Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Journal:

Journal of Clinical Oncology

Published:

2026-03-01

DOI:

10.1200/jco-25-01648

Affiliations:

26

Authors:

52

Go to article

Institutions	Authors	Share
University of Toronto (U of T), Canada	4.500000	0.19
International Hereditary Cancer Center (IHCC), PMU, Poland	3.000000	0.13
McGill University, Canada	1.000000	0.04
Vanderbilt University Medical Center (VUMC), United States of America (USA)	1.000000	0.04
The University of Chicago (UChicago), United States of America (USA)	1.000000	0.04
UCLA Health, United States of America (USA)	1.000000	0.04
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)	1.000000	0.04
Sunnybrook Health Sciences Centre, U of T, Canada	1.000000	0.04
Princess Margaret Cancer Centre, U of T, Canada	1.000000	0.04
Beaumont Hospital - Royal Oak, United States of America (USA)	1.000000	0.04
Hospital de la Santa Creu i Sant Pau, Spain	1.000000	0.04
Mayo Clinic, United States of America (USA)	1.000000	0.04
Comprehensive Cancer Center Vienna (CCC), Austria	1.000000	0.04
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA)	1.000000	0.04
Canada's Michael Smith Genome Sciences Centre (CMSGSC), BCCRC, Canada	1.000000	0.04
Agostino Gemelli University Polyclinic, Italy	0.500000	0.02
Juravinski Cancer Centre, HHS, Canada	0.500000	0.02
McMaster University, Canada	0.500000	0.02
University of Milano-Bicocca (UNIMIB), Italy	0.500000	0.02
San Gerardo Hospital, Italy	0.500000	0.02
Tays Cancer Centre, Finland	0.333333	0.01
Tampere University, Finland	0.333333	0.01
UiO Norwegian Radium Hospital, Norway	0.333333	0.01

Interested in Oncology and Carcinogenesis?